Advertisement

Topics

ElMinda Ltd Product Pipeline Analysis, 2017 Update [Report Updated: 22092017] Prices from USD $750

19:10 EST 12 Nov 2017 | BioPortfolio Reports

Summary


ElMinda Ltd ElMinda is a medical technology company that offers diagnosis of brain disorders and injuries. The company offers tools and technologies in the areas of neuropsychological tests, functional magnetic resonance imaging, positron emission tomography, electroencephalography and magnetic encephalography. Its neuropsychological tests comprise questionnaires, pencil and paper test, computerized NP tests and continuous performance tests and behavioral or performance tests. The company offers research and development programs in the areas of recovery management, pharmacologic treatment optimization, ADHD diagnosis and treatment optimization, and others. It operates in Israel and the US. ElMinda is headquartered in Herzliya, Israel.


This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


Scope:


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company ElMinda Ltd

The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy:


Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research Development strategies

Develop marketentry and market expansion strategies

Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

Original Article: ElMinda Ltd Product Pipeline Analysis, 2017 Update [Report Updated: 22092017] Prices from USD $750

NEXT ARTICLE

More From BioPortfolio on "ElMinda Ltd Product Pipeline Analysis, 2017 Update [Report Updated: 22092017] Prices from USD $750"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...